The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells

Sepsis is a life-threatening health condition that is initially characterized by uncontrolled inflammation, followed by the development of persistent immunosuppression. YCP is a novel α-glucan purified from the mycelium of the marine fungus Phoma herbarum YS4108, which has displayed strong antitumor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acta Pharmacol Sin
Main Authors: Liu, Dan, You, Ming, Zhao, Guang-feng, Li, Xiu-jun, Song, Yu-xian, Dou, Huan, Yao, Wen-bing, Gao, Xiang-dong, Hou, Ya-yi
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589966/
https://ncbi.nlm.nih.gov/pubmed/28649127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.27
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares